The Canadian government is investing CA$3.4 million (US$2.6 million) to help AbCelex Technologies develop a new line of antimicrobial feed additives for the poultry sector.
The company, headquartered in Mississauga, Ontario, is developing a line of non-antibiotic additives specifically targeted at battling Campylobacter and Salmonella, two of the most common food-borne bacteria that infect poultry.
The project will be conducted in collaboration with the International Vaccine Centre at the University of Saskatchewan, the University of Toronto and Colorado Quality Research Inc.
“We are very appreciative to be a recipient of this important funding, said Dr. Saeid Babaei, president and CEO of AbCelex Technologies. “With this visionary contribution and other strategic investments, AbCelex Technologies is well positioned to advance its platform technology and develop next-generation biological products needed for improved human health and a reduction in healthcare costs as a result of food contamination.”
The government’s decision to fund the research was jointly announced in a press release by Canadian Minister of Innovation, Science and Economic Development Navdeep Bains and Minister of Agriculture and Agri-Food Lawrence MacAulay.
“Our government is committed to positioning Canada as a global leader for innovation – one that creates well-paying jobs, drives growth across all industries and improves the lives of all Canadians. Today’s announcement is a prime example of that priority in action: these innovations will reduce the use of antibiotics and result in safer food, a healthier population and a more productive agricultural economy,” stated Bains.